A randomized, controlled trial of initial anti-retroviral therapy with abacavir/lamivudine/zidovudine twice-daily compared to atazanavir once-daily with lamivudine/zidovudine twice...

by McClernon Daniel, Patel Parul, DeJesus Edwin, LaMarca Anthony, Salvato Patricia, Kumar Princy N, Florance Allison, Shaefer Mark S
Published 2009-04-01

Fosamprenavir or atazanavir once daily boosted with ritonavir 100 mg, plus tenofovir/emtricitabine, for the initial treatment of HIV infection: 48-week results of ALERT

by Ross Lisa L, Liao Qiming, Fischl Margaret A, DeJesus Edwin, Weinberg Winkler G, Smith Kimberly Y, Pakes Gary E, Pappa Keith A, Lancaster C Tracey
Published 2008-03-01

Substituting abacavir for hyperlipidemia-associated protease inhibitors in HAART regimens improves fasting lipid profiles, maintains virologic suppression, and simplifies treatment

by Snidow Jerry W, Wakeford John H, Williams Vanessa C, Olliffe Jeffrey F, Rodriguez Allan, DeJesus Edwin, Sension Michael G, Keiser Philip H, Shachoy-Clark Anne D, Fleming Julie W, Pakes Gary E, Hernandez Jaime E
Published 2005-01-01